Advances in Precision Medicine

Editor-in-ChiefAsadullah, Khusru

ISSN: 2424-9106 (Online)

ISSN: 2424-8592 (Print)

Journal Abbreviation: Adv Precis Med

Publication Frequency: bi-annual

Article Processing Charges (APC): Click here for more details

Publishing Model: Open Access

Journal no: 6P

About the Journal

The journal, Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine.

Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

All stages in Biomarker Discovery (research and development) as well as its utilization, i.e. identification, validation and application will be covered. Apart from biomarkers and according assays, novel technologies, strategic and general aspects are of interest too. This includes approaches for marker/assay/device development strategies, collaborative approaches and regulatory aspects with impact on personalized medicine. Novel therapies, even if not guided by biomarkers, may be considered if they specifically target a particular molecule and/or a special patient subpopulation. Validation studies are highly encouraged. APM will also consider publishing negative data.

The target audiences of APM are the scientific and healthcare communities of basic scientists and clinicians from academiaregulatory institutions, and industry. This includes pharmadiagnostic and device companies.

Articles include original articles, reviews, perspectives, editorials, commentaries, position papers, conference reports and letters to the editor. The journal welcomes unsolicited article proposals in all categories except for “Editorials”. Authors are encouraged to refer to APM’s “Section Policies” for more information.

APM provides a vital forum for the exchange of important information in all areas of personalized medicine and biomarker research, development and application. We are devoted to making APM a high-quality, frequently cited journal that publishes superior scholarly articles and disseminates the latest advances in the field.


Announcements

 

Human gut study questions probiotic health benefits

 
Probiotics are found in everything from chocolate and pickles to hand lotion and baby formula, and millions of people buy probiotic supplements to boost digestive health. But new research suggests they might not be as effective as we think. Through a series of experiments looking inside the human gut, researchers show that many people's digestive tracts prevent standard probiotics from successfully colonizing them. Furthermore, taking probiotics to counterbalance antibiotics could delay the return of normal gut bacteria and gut gene expression to their naïve state. The research publishes as two back-to-back papers on September 6 in the journal Cell.  
Posted: 2018-09-11
 

Optimizing technologies for discovering cancer cell mutations

 
After three decades of hopes tempered by setbacks, gene therapy -- the process of treating a disease by modifying a person's DNA -- is no longer the future of medicine, but is part of the present-day clinical treatment toolkit. The Jan. 12 issue of the journal Science provides an in-depth and timely review of the key developments that have led to several successful gene therapy treatments for patients with serious medical conditions.  
Posted: 2018-09-11
 

DNA accessibility, gene expression jointly profiled in thousands of cells

 

Scientists have now developed an assay that concurrently profiles both the epigenome and transcriptome of each of thousands of single cells.

The epigenome and transcriptome are part of the molecular biology that converts a genetic blueprint into tools and materials for living cells.

 
Posted: 2018-09-11
 
More Announcements...